Downregulation of CXXC Finger Protein 4 Leads to a Tamoxifen-resistant Phenotype in Breast Cancer Cells Through Activation of the Wnt/β-catenin Pathway-Reference-Cited by-同舟云学术

Downregulation of CXXC Finger Protein 4 Leads to a Tamoxifen-resistant Phenotype in Breast Cancer Cells Through Activation of the Wnt/β-catenin Pathway

Published:2020-02 Issue:2 Volume:13 Page:423-440
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Fu Yijie,Wang Zhu,Luo Chuanxu,Wang Yu,Wang Yanping,Zhong Xiaorong,Zheng Hong

Funder

National Key Development Plan for Precision Medicine Research

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin. 2018,2018

2. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status;Howlader;J Natl Cancer Inst,2014

3. Breast cancer;Harbeck;Lancet,2017

4. 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3);Cardoso;Ann Oncol,2017

5. Tamoxifen resistance: emerging molecular targets;Rondon-Lagos;Int J Mol Sci,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of circular RNAs in preeclampsia (Review);Experimental and Therapeutic Medicine;2024-07-23

2. Screening fructosamine-3-kinase (FN3K) inhibitors, a deglycating enzyme of oncogenic Nrf2: Human FN3K homology modelling, docking and molecular dynamics simulations;PLOS ONE;2023-11-01

3. Tamoxifen resistance induction results in the upregulation of ABCG2 expression and mitoxantrone resistance in MCF-7 breast cancer cells;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-06-13

4. Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks;International Journal of Biological Macromolecules;2023-03

5. Cancer-derived exosomal circ_0038138 enhances glycolysis, growth, and metastasis of gastric adenocarcinoma via the miR-198/EZH2 axis;Translational Oncology;2022-11